Last updated on August 2019

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)


Find a site near you

Start Over

Yale Cancer Center

New Haven, CT United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

Oschsner Clinic Foundation

New Orleans, LA United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

Tennessee Cancer Specialists

Knoxville, TN United States
  Connect »

Arlington Cancer Center

Arlington, TX United States
  Connect »

Ajou University Hospital

Suwon, Korea, Republic of
  Connect »

Dong-A University Hospital

Busan, Korea, Republic of
  Connect »

Kangbuk Samsung Hospital

Seoul, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Sutter Medical Group

Sacramento, CA United States
  Connect »

Stony Brook Cancer Center

Stony Brook, NY United States
  Connect »

CH de l'Ardenne

Libramont, Belgium
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

AZ Sint Jan

Brugge, Belgium
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

Arlington Cancer Center

Arlington, TX United States
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

UNC- Chapel Hill

Chapel Hill, NC United States
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »

CHU de Saint Etienne

Saint-Étienne, France
  Connect »